Paul Levesque BSc

Paul Levesque is responsible for a global organization of more than 1,250 colleagues who are focused on making a difference in the lives of those affected by rare diseases. His portfolio includes multiple medicines within multiple disease areas, including cardiomyopathy due to transthyretin amyloidosis, hematology, neuroscience, and inherited metabolic disorders. Additionally, alongside the Worldwide Research, Development and Medical (WWRDM) and Clinical Development Heads, Mr. Levesque oversees a robust pipeline, which includes near-term opportunities in Sickle Cell Disease and longer-term opportunities with highly specialized, one-time gene therapy treatments for diseases that have single gene defects, such as certain neuromuscular and hematologic diseases.

Mr. Levesque has nearly 35 years of experience in the biopharmaceutical industry and has held several global senior leadership positions at Pfizer including, from 2016 to 2017, Global Marketing Head, Pfizer Essential Health, and from 2015 to 2016, Global President, Cardiovascular and Metabolic Business. Earlier roles included Regional President, APAC and China, Global Innovative Pharma from 2014-2015 and Regional President, Primary Care (Japan, Korea, Australia/NZ, and Canada) from 2013. Prior to this, he served as Chief Marketing Officer, US Primary Care from 2007 to 2013 and as Country Manager and General Manager, Primary Care – Canada from 2007 to 2012. Mr. Levesque holds a BSc in biochemistry from Laval University, Quebec City, and a Diploma in Management from McGill University, Montreal.